Free tool
FAERS Monitor: Kabiven In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 200656 or its brand name (Kabiven In Plastic Container, Amino Acids, Calcium Chloride, Dextrose, Magnesium Sulfate, Potassium Chloride, Sodium Acetate, Sodium Glycerophosphate, Soybean Oil). Reports on generic versions are filed under their own applications.
Reports
399
Serious
394
99% of reports
Hospitalization
212
Death reported
75
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- chills30
- pyrexia24
- nausea22
- chest discomfort21
- palpitations20
- vomiting20
- death19
- pneumonia19
- asthenia18
- diarrhoea18
- dyspnoea18
- foetal growth restriction17
- anaemia14
- rash maculo-papular14
- cerebral haemorrhage13
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2006 | 5 |
| 2007 | 6 |
| 2008 | 8 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 35 |
| 2013 | 12 |
| 2014 | 10 |
| 2015 | 11 |
| 2016 | 23 |
| 2017 | 24 |
| 2018 | 15 |
| 2019 | 9 |
| 2020 | 11 |
| 2021 | 14 |
| 2022 | 16 |
| 2023 | 79 |
| 2024 | 57 |
| 2025 | 28 |
| 2026 | 13 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,760 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| foetal growth restrictionSignal | 17 | 147.8 | 92.8 | 2,328 |
| rash maculo-papularSignal | 14 | 33.2 | 19.8 | 406 |
| cerebral haemorrhageSignal | 13 | 19.1 | 11.2 | 206 |
| chillsSignal | 30 | 13.5 | 9.6 | 336 |
| chest discomfortSignal | 21 | 10.8 | 7.1 | 178 |
| palpitationsSignal | 20 | 9.0 | 5.9 | 135 |
| anaemiaSignal | 14 | 3.9 | 2.3 | 27 |
| pyrexiaSignal | 24 | 3.7 | 2.5 | 44 |
| pneumoniaSignal | 19 | 3.1 | 2.0 | 25 |
| astheniaSignal | 18 | 2.5 | 1.6 | 15 |
| vomitingSignal | 20 | 2.2 | 1.5 | 13 |
| dyspnoea | 18 | 1.7 | 1.1 | 4 |
| diarrhoea | 18 | 1.5 | 0.9 | 2 |
| nausea | 22 | 1.5 | 1.0 | 3 |
| death | 19 | 1.2 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.